Registered Uganda · NDA

HUMAN PAPILLOMA VIRUS TYPE 6 L1 PROTEIN + HUMAN PAPILLOMA VIRUS TYPE 11 L1 PROTEIN + HUMAN PAPILLOMA VIRUS TYPE 16 L1 PROTEIN + HUMAN PAPILLOMA VIRUS TYPE 18 L1 PROTEIN + HUMAN PAPILLOMA VIRUS TYPE 31 L1 PROTEIN + HUMAN PAPILLOMA VIRUS TYPE 33 PROTEIN + HUMAN PAPILLOMA VIRUS TYPE 45 L1 PROTEIN + HUMAN PAPILLOMA VIRUS TYPE 52 L1 PROTEIN + HUMAN PAPILLOMA VIRUS TYPE 58 L1 PROTEIN

NDA/MAL/HDP/12059 PARENTERAL ORDINARY VIALS 30 µG/0.5ML + 40 µG/0.5ML + 60 µG/0.5ML + 40 µG/0.5ML + 20 µG/0.5ML + 20 µG/0.5ML + 20 µG/0.5ML + 20 µG/0.5ML + 20 µG/0.5ML

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.

NDA/MAL/HDP/12059

Registration date

06/05/2025

Expiry date

Status

Registered

Active ingredient

Dosage form

PARENTERAL ORDINARY VIALS

Strength

30 µG/0.5ML + 40 µG/0.5ML + 60 µG/0.5ML + 40 µG/0.5ML + 20 µG/0.5ML + 20 µG/0.5ML + 20 µG/0.5ML + 20 µG/0.5ML + 20 µG/0.5ML

Pack size

I. 1*1*0.5ML VIAL

Therapeutic class

Manufacturer / MAH

Merck Sharp & Dahme Corp. 770 Sumneytown Pike, West Point, Pennsylvania

Applicant / LTR

MSD PTY LIMITED

Country of origin

UNITED STATES OF AMERICA

Manufacturer location

770 Sumneytown Pike, West Point, PA 19486, USA

Source: National Drug Authority · fetched 2026-04-21 17:37:05 · updated 2026-09-12 04:00:20

Disclaimer: This information is sourced from National Drug Authority (Uganda). Always consult a qualified healthcare professional before using any medication.